{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:41Z","timestamp":1783347881401,"version":"3.54.6"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>The NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome drives interleukin-1 \u03b2-mediated inflammation in endodontic pathologies, including pulpitis and apical periodontitis. Despite advances in chemomechanical preparation techniques, residual inflammation and persistent bacterial infection remain significant challenges. Targeting the NLRP3 inflammasome pathway represents a promising therapeutic strategy. This study evaluated binding interactions of synthetic inhibitors and phytochemicals with NLRP3 inflammasome components using molecular docking and binding free energy calculations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The study aimed to computationally evaluate synthetic and phytochemical inhibitors targeting the NLRP3 inflammasome in endodontic inflammation using molecular docking and molecular mechanics\/generalized born surface area (MM-GBSA) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>Molecular docking simulations using Schr\u00f6dinger Glide Extra Precision mode assessed ligand\u2013target interactions against three critical proteins: full-length NLRP3 (homology model), NLRP3- PyMOL Docking \/ Python docking-related file (ligand or docking preparation file) (PYD) domain Protein Data Bank (3D structure file for proteins\/biomolecules) (PDB: 3QF2), and caspase-1 (PDB: 1RWK). Binding free energies were estimated using MM-GBSA calculations with the OPLS3 force field. The compound library consisted of five phytochemicals and five synthetic inhibitors, all filtered for drug-likeness using Lipinski\u2019s rule of five.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CY-09 exhibited superior NLRP3 binding affinity (Glide Score: \u22126.476 kcal\/mol; MM-GBSA: \u221258.32 kcal\/mol) through hydrogen bonding with Arg351 and hydrophobic interactions. Among phytochemicals, apigenin displayed optimal binding (\u22125.690 kcal\/mol; \u221251.23 kcal\/mol) via hydrogen bonding and \u03c0\u2013\u03c0 stacking. Pralnacasan showed the highest caspase-1 affinity (\u22125.556 kcal\/mol; \u221254.89 kcal\/mol).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This analysis identifies CY-09 and pralnacasan as lead synthetic inhibitors, while establishing apigenin and curcumin as promising phytochemical alternatives. These findings provide a structure-based framework for developing adjunctive anti-inflammatory therapies. Experimental validation through molecular dynamics simulations, cell-based assays, and animal models remains essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcde.jcde_270_26","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:13:37Z","timestamp":1783084417000},"page":"704-710","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Computational evaluation of NOD-like receptor pyrin domain-containing 3 inflammasome inhibitors for endodontic inflammation: A molecular docking analysis of synthetic and phytochemical compounds"],"prefix":"10.4103","volume":"29","author":[{"given":"Ameesha S","family":"Rai","sequence":"first","affiliation":[{"name":"Nitte (Deemed to be University), AB Shetty Memorial Institute of Dental Sciences, Department of Conservative Dentistry & Endodontics, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksha","family":"Bhat","sequence":"additional","affiliation":[{"name":"Nitte (Deemed to be University), AB Shetty Memorial Institute of Dental Sciences, Department of Conservative Dentistry & Endodontics, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Gowdru","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Chemistry, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Kanchan","sequence":"additional","affiliation":[{"name":"Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Chemistry, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethesh","family":"Shetty","sequence":"additional","affiliation":[{"name":"Nitte (Deemed to be University), AB Shetty Memorial Institute of Dental Sciences, Department of Conservative Dentistry & Endodontics, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/iej.13457","article-title":"Bacteria and virulence factors in periapical lesions associated with teeth following primary and secondary root canal treatment","volume":"54","author":"Bronzato","year":"2021","journal-title":"Int Endod J"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/iej.13402","article-title":"Investigation of microbial profile, levels of endotoxin and lipoteichoic acid in teeth with symptomatic irreversible pulpitis: A clinical study","volume":"54","author":"Arruda-Vasconcelos","year":"2021","journal-title":"Int Endod J"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/JCDE.JCDE_289_23","article-title":"Mines of cytokine: A treasure trove in pulpal and periapical diseases","volume":"27","author":"Chandwani","year":"2024","journal-title":"J Conserv Dent Endod"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/iej.13413","article-title":"MicroRNA-223 negatively regulates LPS-induced inflammatory responses by targeting NLRP3 in human dental pulp fibroblasts","volume":"54","author":"Wang","year":"2021","journal-title":"Int Endod J"},{"key":"R5-20260706","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4103\/JCDE.JCDE_324_24","article-title":"Comparision of interleukin-1\u03b2 concentrations in posttreatment endodontic disease and other pulpal and periapical conditions \u2013A clinical study","volume":"27","author":"Jain","year":"2024","journal-title":"J Conserv Dent Endod"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R7-20260706","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K(+) Efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"key":"R10-20260706","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"R13-20260706","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat Chem Biol"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","article-title":"(S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1\u03b2and IL-18","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R17-20260706","first-page":"200","article-title":"Docking study of ligands targeting NLRP3 inflammatory pathway for endodontic diseases","volume":"7","author":"Erdag","year":"2023","journal-title":"Chem Methodol"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and bay 11-7082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J Biol Chem"},{"key":"R19-20260706","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.3390\/molecules27134304","article-title":"Pharmacological properties of 4\u2032,5,7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways","volume":"27","author":"Abid","year":"2022","journal-title":"Molecules"},{"key":"R20-20260706","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/antiox9121228","article-title":"Anti-viral potential and modulation of Nrf2 by curcumin: Pharmacological implications","volume":"9","author":"Rahban","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.09.046","article-title":"Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells","volume":"745","author":"Wu","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"R22-20260706","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: A review","volume":"6","author":"Shao","year":"2015","journal-title":"Front Pharmacol"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/mnfr.201500316","article-title":"Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock","volume":"59","author":"Gong","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"R24-20260706","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/biom13010017","article-title":"Bioactivity and in silico studies of isoquinoline and related alkaloids as promising antiviral agents: an insight","volume":"13","author":"Sharma","year":"2022","journal-title":"Biomolecules"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4103\/JCDE.JCDE_674_25","article-title":"In silico targeting of Enterococcus faecalis proteins in endodontic infections: A systematic review","volume":"28","author":"Geervani","year":"2025","journal-title":"J Conserv Dent Endod"},{"key":"R26-20260706","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"R27-20260706","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"R28-20260706","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4103\/JCDE.JCDE_268_24","article-title":"Data-driven dentistry: Computational revelations redefining pulp capping","volume":"27","author":"Kumar","year":"2024","journal-title":"J Conserv Dent Endod"},{"key":"R29-20260706","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"R30-20260706","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"R31-20260706","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J Chem Theory Comput"},{"key":"R32-20260706","first-page":"936","article-title":"Molecular mechanism of Eucommia ulmoides against osteoporosis based on network pharmacology","volume":"20","author":"Li","year":"2018","journal-title":"Mod Chin Med"},{"key":"R33-20260706","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.3390\/molecules25235533","article-title":"Inhibiting the NLRP3 inflammasome","volume":"25","author":"El-Sharkawy","year":"2020","journal-title":"Molecules"},{"key":"R34-20260706","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"R35-20260706","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.joen.2008.07.028","article-title":"Clinical implications and microbiology of bacterial persistence after treatment procedures","volume":"34","author":"Siqueira","year":"2008","journal-title":"J Endod"},{"key":"R36-20260706","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4103\/JCDE.JCDE_416_25","article-title":"Antibacterial efficacy and molecular docking analysis of Zingiber offinale and Allium sativum against Fusobacterium nucleatum \u2013An in vitro study","volume":"28","author":"Jayakumar","year":"2025","journal-title":"J Conserv Dent Endod"}],"container-title":["Journal of Conservative Dentistry and Endodontics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/JCDE.JCDE_270_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:47:56Z","timestamp":1783345676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/JCDE.JCDE_270_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcde.jcde_270_26","relation":{},"ISSN":["2950-4716","2950-4708"],"issn-type":[{"value":"2950-4716","type":"print"},{"value":"2950-4708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-03-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}